Meritage Starts Study of Inflammatory Disease

1/22/09Follow @xconomy

Meritage Pharma, a San Diego-based drug developer, said today it has started a mid-stage clinical trial of an experimental drug for an inflammatory condition of the esophagus, called eosinophilic esophagitis. The trial will enroll 80 children and young adults on three different doses of the Meritage drug or a placebo. We profiled this company’s technology in detail back in December.

By posting a comment, you agree to our terms and conditions.